United States Biotechnology & Medical Research

Dendreon Corp (DNDNQ)

Track

Ticker: DNDNQ Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Brophy Karen VP, Human Resources Officer
Transaction date
Sale
Price
213.72
Quantity 84,585 -23.5%
Value US$3,070,846
Brophy Karen VP, Human Resources Officer
Transaction date
Sale
Price
259.28
Quantity 60,692 -20.0%
Value US$3,871,018
Pacheco Silvio SVP, Sales and Marketing Officer
Transaction date
Sale
Price
122.32
Quantity 89,779 -35.6%
Value US$1,289,168
Pacheco Silvio SVP, Sales and Marketing Officer
Transaction date
Sale
Price
0.08
Quantity 2,500 -2.5%
Value US$202
Crotty Robert EVP, General Counsel Officer
Transaction date
Sale
Price
0.08
Quantity 21,764 -18.2%
Value US$1,765
Monteith William EVP, Technical Operations Officer
Transaction date
Sale
Price
0.08
Quantity 96,690 -31.5%
Value US$7,300
Cox Greg EVP, CFO & Treasurer Officer
Transaction date
Sale
Price
0.09
Quantity 4,021 -2.2%
Value US$372
Sandler Andrew Seth EVP, Chief Medical Officer Officer
Transaction date
Sale
Price
0.09
Quantity 105,925 -33.8%
Value US$9,470
Monteith William EVP, Technical Operations Officer
Transaction date
Sale
Price
0.09
Quantity 1,284 -0.4%
Value US$112
Cox Greg EVP, CFO & Treasurer Officer
Transaction date
Sale
Price
0.09
Quantity 110,133 -37.7%
Value US$10,132
Sandler Andrew Seth EVP, Chief Medical Officer Officer
Transaction date
Sale
Price
0.09
Quantity 7,791 -2.4%
Value US$704
Rocco Lindsay EVP, Corporate Communications Officer
Transaction date
Sale
Price
2.94
Quantity 8,207 -6.8%
Value US$24,145
CANET GERARDO Non-Executive Director
Transaction date
Purchase
Price
4.38
Quantity 10,000 +25.2%
Value US$43,799
Frohlich Mark W See General Remarks Officer
Transaction date
Sale
Price
7.20
Quantity 7,500 -4.0%
Value US$53,998
SCHIFFMAN GREGORY T CFO, SVP of Finance & Treasure Officer
Transaction date
Purchase
Price
6.66
Quantity 30,030 +14.2%
Value US$200,000
JOHNSON JOHN Non-Executive Director
Transaction date
Purchase
Price
6.68
Quantity 2,500 +23.9%
Value US$16,689
URDAL DAVID SVP, Chief Scientific Officer Officer
Transaction date
Planned sale
Price
9.65
Quantity 2,036 -0.3%
Value US$19,647
BAYH SUSAN B Non-Executive Director
Transaction date
Purchase
Price
11.05
Quantity 20,000 +96.4%
Value US$220,958
GOLD MITCHELL President & Chief Executive Of Officer
Transaction date
Planned sale
Price
38.37
Quantity 3,881 -1.7%
Value US$148,900
URDAL DAVID SVP, Chief Scientific Officer Officer
Transaction date
Planned sale
Price
38.43
Quantity 2,035 -0.4%
Value US$78,205
GOLD MITCHELL President & Chief Executive Of Officer
Transaction date
Planned sale
Price
38.69
Quantity 15,119 -5.7%
Value US$585,001
GOLD MITCHELL President & Chief Executive Of Officer
Transaction date
Planned sale
Price
38.69
Quantity 3,881 -1.4%
Value US$150,168
CANET GERARDO Non-Executive Director
Transaction date
Sale
Price
41.38
Quantity 5,000 -25.3%
Value US$206,900
RANIERI RICHARD J SVP, Human Resources Officer
Transaction date
Sale
Price
41.00
Quantity 6,371 -10.0%
Value US$261,211
Cox Greg VP, Finance Officer
Transaction date
Sale
Price
40.70
Quantity 11,174 -32.6%
Value US$454,782
Cox Greg VP, Finance Officer
Transaction date
Sale
Price
40.70
Quantity 475 -1.4%
Value US$19,332
Cox Greg VP, Finance Officer
Transaction date
Sale
Price
40.70
Quantity 1,157 -3.4%
Value US$47,090
Cox Greg VP, Finance Officer
Transaction date
Sale
Price
40.70
Quantity 3,038 -8.9%
Value US$123,647
GOLD MITCHELL President & Chief Executive Of Officer
Transaction date
Planned sale
Price
40.00
Quantity 15,119 -5.4%
Value US$604,712
Cox Greg VP, Finance Officer
Transaction date
Sale
Price
40.70
Quantity 4,156 -12.1%
Value US$169,149
HAMM RICHARD F JR EVP, General Counsel Secretary Officer
Transaction date
Sale
Price
39.08
Quantity 51,457 -22.2%
Value US$2,011,017
HAMM RICHARD F JR SVP, General Counsel Secretary Officer
Transaction date
Sale
Price
39.18
Quantity 7,707 -3.2%
Value US$301,983
HAMM RICHARD F JR SVP, General Counsel Secretary Officer
Transaction date
Sale
Price
39.18
Quantity 1,406 -0.6%
Value US$55,091
GOLD MITCHELL President & Chief Executive Of Officer
Transaction date
Planned sale
Price
40.71
Quantity 19,000 -6.3%
Value US$773,454
URDAL DAVID SVP, Chief Scientific Officer Officer
Transaction date
Planned sale
Price
41.68
Quantity 2,035 -0.3%
Value US$84,819
URDAL DAVID SVP, Chief Scientific Officer Officer
Transaction date
Planned sale
Price
41.58
Quantity 8,898 -1.5%
Value US$369,979
GOLD MITCHELL President & Chief Executive Of Officer
Transaction date
Planned sale
Price
33.21
Quantity 19,000 -6.2%
Value US$630,908
DZIURZYNSKI BOGDAN Non-Executive Director
Transaction date
Sale
Price
32.93
Quantity 33,000 -53.7%
Value US$1,086,703
GOLD MITCHELL President & Chief Executive Of Officer
Transaction date
Planned sale
Price
33.03
Quantity 6,500 -2.2%
Value US$214,673
GOLD MITCHELL President & Chief Executive Of Officer
Transaction date
Planned sale
Price
33.03
Quantity 11,701 -3.9%
Value US$386,444
GOLD MITCHELL President & Chief Executive Of Officer
Transaction date
Planned sale
Price
33.03
Quantity 799 -0.3%
Value US$26,388
Frohlich Mark W See Remarks Officer
Transaction date
Planned sale
Price
35.27
Quantity 2,250 -1.1%
Value US$79,347
CANET GERARDO Non-Executive Director
Transaction date
Sale
Price
36.32
Quantity 4,456 -21.5%
Value US$161,837
Frohlich Mark W see remarks Officer
Transaction date
Sale
Price
38.44
Quantity 7,896 -4.3%
Value US$303,536
SCHIFFMAN GREGORY T CFO, SVP of Finance & Treasure Officer
Transaction date
Sale
Price
37.84
Quantity 27,000 -12.1%
Value US$1,021,772
HAMM RICHARD F JR SVP, General Counsel Secretary Officer
Transaction date
Sale
Price
41.70
Quantity 9,667 -4.6%
Value US$403,114
HAMM RICHARD F JR SVP, General Counsel Secretary Officer
Transaction date
Sale
Price
42.10
Quantity 4,817 -2.2%
Value US$202,796
HAMM RICHARD F JR SVP, General Counsel Secretary Officer
Transaction date
Sale
Price
42.10
Quantity 2,344 -1.1%
Value US$98,683
URDAL DAVID SVP, Chief Scientific Officer Officer
Transaction date
Planned sale
Price
42.55
Quantity 10,000 -1.5%
Value US$425,500
URDAL DAVID SVP, Chief Scientific Officer Officer
Transaction date
Planned sale
Price
42.00
Quantity 5,000 -0.7%
Value US$210,000
URDAL DAVID SVP, Chief Scientific Officer Officer
Transaction date
Planned sale
Price
40.37
Quantity 5,000 -0.7%
Value US$201,850
URDAL DAVID SVP, Chief Scientific Officer Officer
Transaction date
Planned sale
Price
40.41
Quantity 5,000 -0.7%
Value US$202,050
URDAL DAVID SVP, Chief Scientific Officer Officer
Transaction date
Planned sale
Price
41.00
Quantity 5,000 -0.7%
Value US$205,000
CLARK IAN T Board of Director Non-Executive Director
Transaction date
Sale
Price
37.46
Quantity 7,500 -100.0%
Value US$280,967
URDAL DAVID SVP, Chief Scientific Officer Officer
Transaction date
Sale
Price
39.21
Quantity 40,000 -5.2%
Value US$1,568,300
DZIURZYNSKI BOGDAN Non-Executive Director
Transaction date
Sale
Price
39.05
Quantity 16,250 -39.4%
Value US$634,593
CANET GERARDO Non-Executive Director
Transaction date
Sale
Price
43.54
Quantity 4,000 -16.2%
Value US$174,176
DZIURZYNSKI BOGDAN Board of Director Non-Executive Director
Transaction date
Sale
Price
44.34
Quantity 10,000 -19.5%
Value US$443,397
DZIURZYNSKI BOGDAN Board of Director Non-Executive Director
Transaction date
Sale
Price
44.34
Quantity 10,000 -19.5%
Value US$443,397
DZIURZYNSKI BOGDAN Board of Director Non-Executive Director
Transaction date
Sale
Price
44.34
Quantity 10,000 -19.5%
Value US$443,397
BREWER RICHARD B Board of Director Non-Executive Director
Transaction date
Sale
Price
53.16
Quantity 4,000 -19.4%
Value US$212,640
CLARK IAN T Board of Director Non-Executive Director
Transaction date
Sale
Price
54.61
Quantity 8,744 -100.0%
Value US$477,510
Cox Greg VP of Accounting Officer
Transaction date
Sale
Price
55.11
Quantity 14,460 -40.1%
Value US$796,920
Cox Greg VP of Accounting Officer
Transaction date
Sale
Price
55.43
Quantity 2,804 -7.2%
Value US$155,426
Cox Greg VP of Accounting Officer
Transaction date
Sale
Price
55.11
Quantity 1,250 -3.3%
Value US$68,890
Cox Greg VP of Accounting Officer
Transaction date
Sale
Price
55.11
Quantity 4,375 -10.8%
Value US$241,115
HAMM RICHARD F JR SVP, General Counsel Secretary Officer
Transaction date
Sale
Price
56.85
Quantity 9,000 -6.3%
Value US$511,690
WATSON DOUGLAS G Board of Director Non-Executive Director
Transaction date
Sale
Price
56.56
Quantity 7,500 -22.2%
Value US$424,234
WATSON DOUGLAS G Board of Director Non-Executive Director
Transaction date
Sale
Price
56.56
Quantity 28,671 -52.2%
Value US$1,621,764
URDAL DAVID SVP, Chief Scientific Officer Officer
Transaction date
Sale
Price
53.93
Quantity 7,732 -1.2%
Value US$417,015
URDAL DAVID SVP, Chief Scientific Officer Officer
Transaction date
Sale
Price
53.93
Quantity 32,268 -4.7%
Value US$1,740,333
Frohlich Mark W See Remarks Officer
Transaction date
Sale
Price
54.44
Quantity 43,599 -21.3%
Value US$2,373,530
HAMM RICHARD F JR SVP, General Counsel Secretary Officer
Transaction date
Sale
Price
56.36
Quantity 89,227 -38.4%
Value US$5,029,226
HAMM RICHARD F JR SVP, General Counsel Secretary Officer
Transaction date
Sale
Price
54.99
Quantity 26,973 -10.4%
Value US$1,483,359
HAMM RICHARD F JR SVP, General Counsel Secretary Officer
Transaction date
Sale
Price
54.99
Quantity 18,750 -7.5%
Value US$1,031,141
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2015-02-19 2015-02-19 S Sale Brophy Karen

VP, Human Resources

Officer
84,585 -23.5%
213.72
US$3,070,846 		84,585 -23.5% 213.72 US$3,070,846
2015-02-19 2015-02-19 S Sale Brophy Karen

VP, Human Resources

Officer
60,692 -20.0%
259.28
US$3,871,018 		60,692 -20.0% 259.28 US$3,871,018
2015-02-18 2015-02-18 S Sale Pacheco Silvio

SVP, Sales and Marketing

Officer
89,779 -35.6%
122.32
US$1,289,168 		89,779 -35.6% 122.32 US$1,289,168
2015-02-18 2015-02-17 S Sale Pacheco Silvio

SVP, Sales and Marketing

Officer
2,500 -2.5%
0.08
US$202 		2,500 -2.5% 0.08 US$202
2015-02-18 2015-02-17 S Sale Crotty Robert

EVP, General Counsel

Officer
21,764 -18.2%
0.08
US$1,765 		21,764 -18.2% 0.08 US$1,765
2015-02-17 2015-02-17 S Sale Monteith William

EVP, Technical Operations

Officer
96,690 -31.5%
0.08
US$7,300 		96,690 -31.5% 0.08 US$7,300
2015-02-17 2015-02-13 S Sale Cox Greg

EVP, CFO & Treasurer

Officer
4,021 -2.2%
0.09
US$372 		4,021 -2.2% 0.09 US$372
2015-02-17 2015-02-13 S Sale Sandler Andrew Seth

EVP, Chief Medical Officer

Officer
105,925 -33.8%
0.09
US$9,470 		105,925 -33.8% 0.09 US$9,470
2015-02-17 2015-02-13 S Sale Monteith William

EVP, Technical Operations

Officer
1,284 -0.4%
0.09
US$112 		1,284 -0.4% 0.09 US$112
2015-02-17 2015-02-13 S Sale Cox Greg

EVP, CFO & Treasurer

Officer
110,133 -37.7%
0.09
US$10,132 		110,133 -37.7% 0.09 US$10,132
2015-02-17 2015-02-13 S Sale Sandler Andrew Seth

EVP, Chief Medical Officer

Officer
7,791 -2.4%
0.09
US$704 		7,791 -2.4% 0.09 US$704
2014-01-10 2013-12-10 S Sale Rocco Lindsay

EVP, Corporate Communications

Officer
8,207 -6.8%
2.94
US$24,145 		8,207 -6.8% 2.94 US$24,145
2012-08-02 2012-08-01 B Purchase CANET GERARDO Non-Executive Director
10,000 +25.2%
4.38
US$43,799 		10,000 +25.2% 4.38 US$43,799
2011-11-16 2011-11-14 S Sale Frohlich Mark W

See General Remarks

Officer
7,500 -4.0%
7.20
US$53,998 		7,500 -4.0% 7.20 US$53,998
2011-11-07 2011-11-07 B Purchase SCHIFFMAN GREGORY T

CFO, SVP of Finance & Treasure

Officer
30,030 +14.2%
6.66
US$200,000 		30,030 +14.2% 6.66 US$200,000
2011-11-07 2011-11-04 B Purchase JOHNSON JOHN Non-Executive Director
2,500 +23.9%
6.68
US$16,689 		2,500 +23.9% 6.68 US$16,689
2011-10-19 2011-10-17 PlS Planned sale URDAL DAVID

SVP, Chief Scientific Officer

Officer
2,036 -0.3%
9.65
US$19,647 		2,036 -0.3% 9.65 US$19,647
2011-09-13 2011-09-09 B Purchase BAYH SUSAN B Non-Executive Director
20,000 +96.4%
11.05
US$220,958 		20,000 +96.4% 11.05 US$220,958
2011-07-26 2011-07-25 PlS Planned sale GOLD MITCHELL

President & Chief Executive Of

Officer
3,881 -1.7%
38.37
US$148,900 		3,881 -1.7% 38.37 US$148,900
2011-07-19 2011-07-17 PlS Planned sale URDAL DAVID

SVP, Chief Scientific Officer

Officer
2,035 -0.4%
38.43
US$78,205 		2,035 -0.4% 38.43 US$78,205
2011-06-28 2011-06-27 PlS Planned sale GOLD MITCHELL

President & Chief Executive Of

Officer
15,119 -5.7%
38.69
US$585,001 		15,119 -5.7% 38.69 US$585,001
2011-06-28 2011-06-27 PlS Planned sale GOLD MITCHELL

President & Chief Executive Of

Officer
3,881 -1.4%
38.69
US$150,168 		3,881 -1.4% 38.69 US$150,168
2011-06-07 2011-06-03 S Sale CANET GERARDO Non-Executive Director
5,000 -25.3%
41.38
US$206,900 		5,000 -25.3% 41.38 US$206,900
2011-05-31 2011-05-26 S Sale RANIERI RICHARD J

SVP, Human Resources

Officer
6,371 -10.0%
41.00
US$261,211 		6,371 -10.0% 41.00 US$261,211
2011-05-27 2011-05-25 S Sale Cox Greg

VP, Finance

Officer
11,174 -32.6%
40.70
US$454,782 		11,174 -32.6% 40.70 US$454,782
2011-05-27 2011-05-25 S Sale Cox Greg

VP, Finance

Officer
475 -1.4%
40.70
US$19,332 		475 -1.4% 40.70 US$19,332
2011-05-27 2011-05-25 S Sale Cox Greg

VP, Finance

Officer
1,157 -3.4%
40.70
US$47,090 		1,157 -3.4% 40.70 US$47,090
2011-05-27 2011-05-25 S Sale Cox Greg

VP, Finance

Officer
3,038 -8.9%
40.70
US$123,647 		3,038 -8.9% 40.70 US$123,647
2011-05-27 2011-05-25 PlS Planned sale GOLD MITCHELL

President & Chief Executive Of

Officer
15,119 -5.4%
40.00
US$604,712 		15,119 -5.4% 40.00 US$604,712
2011-05-27 2011-05-25 S Sale Cox Greg

VP, Finance

Officer
4,156 -12.1%
40.70
US$169,149 		4,156 -12.1% 40.70 US$169,149
2011-05-25 2011-05-23 S Sale HAMM RICHARD F JR

EVP, General Counsel Secretary

Officer
51,457 -22.2%
39.08
US$2,011,017 		51,457 -22.2% 39.08 US$2,011,017
2011-05-10 2011-05-06 S Sale HAMM RICHARD F JR

SVP, General Counsel Secretary

Officer
7,707 -3.2%
39.18
US$301,983 		7,707 -3.2% 39.18 US$301,983
2011-05-10 2011-05-06 S Sale HAMM RICHARD F JR

SVP, General Counsel Secretary

Officer
1,406 -0.6%
39.18
US$55,091 		1,406 -0.6% 39.18 US$55,091
2011-04-26 2011-04-25 PlS Planned sale GOLD MITCHELL

President & Chief Executive Of

Officer
19,000 -6.3%
40.71
US$773,454 		19,000 -6.3% 40.71 US$773,454
2011-04-19 2011-04-18 PlS Planned sale URDAL DAVID

SVP, Chief Scientific Officer

Officer
2,035 -0.3%
41.68
US$84,819 		2,035 -0.3% 41.68 US$84,819
2011-04-19 2011-04-15 PlS Planned sale URDAL DAVID

SVP, Chief Scientific Officer

Officer
8,898 -1.5%
41.58
US$369,979 		8,898 -1.5% 41.58 US$369,979
2011-03-29 2011-03-25 PlS Planned sale GOLD MITCHELL

President & Chief Executive Of

Officer
19,000 -6.2%
33.21
US$630,908 		19,000 -6.2% 33.21 US$630,908
2011-03-15 2011-03-11 S Sale DZIURZYNSKI BOGDAN Non-Executive Director
33,000 -53.7%
32.93
US$1,086,703 		33,000 -53.7% 32.93 US$1,086,703
2011-03-07 2011-03-03 PlS Planned sale GOLD MITCHELL

President & Chief Executive Of

Officer
6,500 -2.2%
33.03
US$214,673 		6,500 -2.2% 33.03 US$214,673
2011-03-07 2011-03-03 PlS Planned sale GOLD MITCHELL

President & Chief Executive Of

Officer
11,701 -3.9%
33.03
US$386,444 		11,701 -3.9% 33.03 US$386,444
2011-03-07 2011-03-03 PlS Planned sale GOLD MITCHELL

President & Chief Executive Of

Officer
799 -0.3%
33.03
US$26,388 		799 -0.3% 33.03 US$26,388
2011-01-24 2011-01-21 PlS Planned sale Frohlich Mark W

See Remarks

Officer
2,250 -1.1%
35.27
US$79,347 		2,250 -1.1% 35.27 US$79,347
2010-12-16 2010-12-14 S Sale CANET GERARDO Non-Executive Director
4,456 -21.5%
36.32
US$161,837 		4,456 -21.5% 36.32 US$161,837
2010-12-07 2010-12-03 S Sale Frohlich Mark W

see remarks

Officer
7,896 -4.3%
38.44
US$303,536 		7,896 -4.3% 38.44 US$303,536
2010-11-22 2010-11-19 S Sale SCHIFFMAN GREGORY T

CFO, SVP of Finance & Treasure

Officer
27,000 -12.1%
37.84
US$1,021,772 		27,000 -12.1% 37.84 US$1,021,772
2010-09-17 2010-09-16 S Sale HAMM RICHARD F JR

SVP, General Counsel Secretary

Officer
9,667 -4.6%
41.70
US$403,114 		9,667 -4.6% 41.70 US$403,114
2010-09-17 2010-09-16 S Sale HAMM RICHARD F JR

SVP, General Counsel Secretary

Officer
4,817 -2.2%
42.10
US$202,796 		4,817 -2.2% 42.10 US$202,796
2010-09-17 2010-09-16 S Sale HAMM RICHARD F JR

SVP, General Counsel Secretary

Officer
2,344 -1.1%
42.10
US$98,683 		2,344 -1.1% 42.10 US$98,683
2010-09-09 2010-09-09 PlS Planned sale URDAL DAVID

SVP, Chief Scientific Officer

Officer
10,000 -1.5%
42.55
US$425,500 		10,000 -1.5% 42.55 US$425,500
2010-09-09 2010-09-08 PlS Planned sale URDAL DAVID

SVP, Chief Scientific Officer

Officer
5,000 -0.7%
42.00
US$210,000 		5,000 -0.7% 42.00 US$210,000
2010-09-09 2010-09-08 PlS Planned sale URDAL DAVID

SVP, Chief Scientific Officer

Officer
5,000 -0.7%
40.37
US$201,850 		5,000 -0.7% 40.37 US$201,850
2010-09-09 2010-09-07 PlS Planned sale URDAL DAVID

SVP, Chief Scientific Officer

Officer
5,000 -0.7%
40.41
US$202,050 		5,000 -0.7% 40.41 US$202,050
2010-09-03 2010-09-03 PlS Planned sale URDAL DAVID

SVP, Chief Scientific Officer

Officer
5,000 -0.7%
41.00
US$205,000 		5,000 -0.7% 41.00 US$205,000
2010-08-23 2010-08-20 S Sale CLARK IAN T

Board of Director

Non-Executive Director
7,500 -100.0%
37.46
US$280,967 		7,500 -100.0% 37.46 US$280,967
2010-08-05 2010-08-04 S Sale URDAL DAVID

SVP, Chief Scientific Officer

Officer
40,000 -5.2%
39.21
US$1,568,300 		40,000 -5.2% 39.21 US$1,568,300
2010-06-15 2010-06-14 S Sale DZIURZYNSKI BOGDAN Non-Executive Director
16,250 -39.4%
39.05
US$634,593 		16,250 -39.4% 39.05 US$634,593
2010-05-27 2010-05-26 S Sale CANET GERARDO Non-Executive Director
4,000 -16.2%
43.54
US$174,176 		4,000 -16.2% 43.54 US$174,176
2010-05-25 2010-05-24 S Sale DZIURZYNSKI BOGDAN

Board of Director

Non-Executive Director
10,000 -19.5%
44.34
US$443,397 		10,000 -19.5% 44.34 US$443,397
2010-05-25 2010-05-24 S Sale DZIURZYNSKI BOGDAN

Board of Director

Non-Executive Director
10,000 -19.5%
44.34
US$443,397 		10,000 -19.5% 44.34 US$443,397
2010-05-25 2010-05-24 S Sale DZIURZYNSKI BOGDAN

Board of Director

Non-Executive Director
10,000 -19.5%
44.34
US$443,397 		10,000 -19.5% 44.34 US$443,397
2010-05-07 2010-05-05 S Sale BREWER RICHARD B

Board of Director

Non-Executive Director
4,000 -19.4%
53.16
US$212,640 		4,000 -19.4% 53.16 US$212,640
2010-05-06 2010-05-03 S Sale CLARK IAN T

Board of Director

Non-Executive Director
8,744 -100.0%
54.61
US$477,510 		8,744 -100.0% 54.61 US$477,510
2010-05-05 2010-05-03 S Sale Cox Greg

VP of Accounting

Officer
14,460 -40.1%
55.11
US$796,920 		14,460 -40.1% 55.11 US$796,920
2010-05-05 2010-05-03 S Sale Cox Greg

VP of Accounting

Officer
2,804 -7.2%
55.43
US$155,426 		2,804 -7.2% 55.43 US$155,426
2010-05-05 2010-05-03 S Sale Cox Greg

VP of Accounting

Officer
1,250 -3.3%
55.11
US$68,890 		1,250 -3.3% 55.11 US$68,890
2010-05-05 2010-05-03 S Sale Cox Greg

VP of Accounting

Officer
4,375 -10.8%
55.11
US$241,115 		4,375 -10.8% 55.11 US$241,115
2010-09-17 2010-04-30 S Sale HAMM RICHARD F JR

SVP, General Counsel Secretary

Officer
9,000 -6.3%
56.85
US$511,690 		9,000 -6.3% 56.85 US$511,690
2010-05-04 2010-04-30 S Sale WATSON DOUGLAS G

Board of Director

Non-Executive Director
7,500 -22.2%
56.56
US$424,234 		7,500 -22.2% 56.56 US$424,234
2010-05-04 2010-04-30 S Sale WATSON DOUGLAS G

Board of Director

Non-Executive Director
28,671 -52.2%
56.56
US$1,621,764 		28,671 -52.2% 56.56 US$1,621,764
2010-05-04 2010-04-30 S Sale URDAL DAVID

SVP, Chief Scientific Officer

Officer
7,732 -1.2%
53.93
US$417,015 		7,732 -1.2% 53.93 US$417,015
2010-05-04 2010-04-30 S Sale URDAL DAVID

SVP, Chief Scientific Officer

Officer
32,268 -4.7%
53.93
US$1,740,333 		32,268 -4.7% 53.93 US$1,740,333
2010-05-04 2010-04-30 S Sale Frohlich Mark W

See Remarks

Officer
43,599 -21.3%
54.44
US$2,373,530 		43,599 -21.3% 54.44 US$2,373,530
2010-05-03 2010-04-30 S Sale HAMM RICHARD F JR

SVP, General Counsel Secretary

Officer
89,227 -38.4%
56.36
US$5,029,226 		89,227 -38.4% 56.36 US$5,029,226
2010-05-03 2010-04-30 S Sale HAMM RICHARD F JR

SVP, General Counsel Secretary

Officer
26,973 -10.4%
54.99
US$1,483,359 		26,973 -10.4% 54.99 US$1,483,359
2010-05-03 2010-04-30 S Sale HAMM RICHARD F JR

SVP, General Counsel Secretary

Officer
18,750 -7.5%
54.99
US$1,031,141 		18,750 -7.5% 54.99 US$1,031,141
Explore more

More insider trading research around Dendreon Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America